Mucosal microbiota and gene expression are associated with long-term remission after discontinuation of adalimumab in ulcerative colitis

Given that sustained remission is the ultimate treatment goal in the management of patients with ulcerative colitis (UC), the decision to stop anti-tumor necrosis factor (anti-TNF) treatment in UC patients is difficult. The aim of this study was to evaluate mucosal microbiota and gene expression pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakurai, Toshiharu, Nishiyama, Hiroki, Sakai, Kazuko, De Velasco, Marco A., Nagai, Tomoyuki, Komeda, Yoriaki, Kashida, Hiroshi, Okada, Akiyoshi, Kawai, Isao, Nishio, Kazuto, Ogata, Hiroyuki, Kudo, Masatoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644643/
https://www.ncbi.nlm.nih.gov/pubmed/33154436
http://dx.doi.org/10.1038/s41598-020-76175-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644643/
https://www.ncbi.nlm.nih.gov/pubmed/33154436
http://dx.doi.org/10.1038/s41598-020-76175-2

Ejemplares similares